New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For GE;DELL;GSK;AZN;BEN;AAPL From The Last 14 Days
Check below for free stories on GE;DELL;GSK;AZN;BEN;AAPL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>
April 22, 2014
05:26 EDTGSKNovartis OTC, GSK Consumer Healthcare form joint venture
Subscribe for More Information
05:23 EDTGSKNovartis divests Vaccines business to GSK for $7.1B
Novartis (NVS) has agreed to divest its Vaccines business to GSK (GSK), currently excluding its flu business, for $7.1B plus royalties. The $7.1B consists of $5.25B upfront and up to $1.8B in milestones. As a part of a value-maximization strategy in the context of the portfolio review, Novartis has initiated a separate sales process for its flu business.
05:20 EDTGSKNovartis to acquire GSK oncology products for $14.5B
Subscribe for More Information
April 21, 2014
16:40 EDTAZNOn The Fly: Closing Wrap
Stocks on Wall Street were higher for the fifth straight session. Volume remained light on this Monday following Easter, as a number of international markets remained closed. The averages spent time on both sides of the flat-line early in the trading day before settling into a narrow range in positive territory for most of the second half of the session. ECONOMIC EVENTS: In the U.S., the Chicago Fed national activity index fell to 0.20 in March, matching the consensus forecast. The Conference Board's index of leading indicators rose 0.8% in March, beating the consensus forecast for an increase of 0.7%. COMPANY NEWS: Ford (F) is preparing to announce that its Chief Operating Officer, Mike Fields, will take the CEO role at the company following the retirement of current CEO Alan Mulally later this year, according to a report from Bloomberg. Shares of Ford were little changed for the session following the report, losing 2c, or 0.13%, to close at $15.98... U.S.-listed shares of British pharmaceutical company AstraZeneca (AZN) gained $5.61, or 8.84%, to $69.10 after the U.K.'s Sunday Times said Pfizer (PFE) has takeover interest in the company. Analysts had mixed opinions on the report, with Citigroup saying a bid looks "highly probable," while analysts at Bernstein think such a deal would conflict with Pfizer's strategy of getting smaller. Shares of Pfizer rose 61c, or 2.02%, to $30.86 following the report... MAJOR MOVERS: Among the notable gainers was Sarepta Therapeutics (SRPT), up $9.58, or 39.26%, to $33.98 after announcing plans to submit a New Drug Application to the FDA by the end of this year for the approval of eteplirsen for the treatment of Duchenne muscular dystrophy. Also higher was Advanced Micro Devices (AMD), which rose 43c, or 11.65%, to $4.12 after the semiconductor manufacturer reported earnings and revenue that topped expectations after the close on Thursday. Among the noteworthy losers was MoneyGram (MGI), down $2.01, or 13.57%, to $12.80 in its second straight losing session after Wal-Mart (WMT) announced that it was launching its own money transfer service. MoneyGram's slide today comes after the stock dropped by more than 18% on Thursday following Wal-Mart's announcement. Also lower was lululemon (LULU), down $2.64, or 5.11%, to $49.07 after analysts at Sterne Agee said the company's investor day presentation, held on Thursday, did not include a substantive plan to grow same-store sales. INDEXES: The Dow was up 40.71, or 0.25%, to 16,449.25, the Nasdaq was up 26.03, or 0.64%, to 4,121.55, and the S&P 500 was up 7.04, or 0.38%, to 1,871.89.
16:01 EDTAAPLOptions Update; April 21, 2014
iPath S&P 500 VIX Short-Term Futures down 78c to 40.03. Option volume leaders: AAPL C GILD NFLX TSLA TWTR FB WLT according to Track Data.
15:05 EDTAAPLApple recruiting employees for mobile payments, Re/code says
Subscribe for More Information
14:40 EDTAAPLWi-LAN files appeal in patent suit with Apple
Wi-LAN (WILN) announced that it has filed an appeal with the United States Court of Appeals for the Federal Circuit in its patent dispute with Apple (AAPL) involving WiLAN's U.S. Patent No. RE37,802. On April 3, Judge Rodney Gilstrap of the U.S. District Court for the Eastern District of Texas, ruled that the Jury had no basis for invalidating the 802 patent at the trial of the WiLAN vs. Apple lawsuit in October 2013. In addition to this case, WiLAN is in litigation with Apple in the Southern District of California concerning the infringement of two patents related to LTE technology. WiLAN expects the case in Southern California to go to trial later this year if not settled earlier.
12:47 EDTAZNOn The Fly: Midday Wrap
Subscribe for More Information
11:34 EDTAAPLApple April weekly volatility elevated at 50 into Q2
Subscribe for More Information
10:18 EDTAZNAnalysts differ on chances of Pfizer interest in AstraZeneca
Subscribe for More Information
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:32 EDTAAPLJabil Circuit downgraded at RBC Capital
As noted earlier, RBC Capital downgraded Jabil Circuit (JBL) to Sector Perform from Outperform. As reasons for the downgrade, the firm cited concerns about Jabil circuit's largest customer, Apple (AAPL), as well as its belief that Jabil's FY15 guidance appears to reflect a best-case scenario. Target to $20 from $21.
09:21 EDTAZNOn The Fly: Pre-Market Movers
HIGHER: Sarepta (SRPT), up 54% after announcing plans to to submit NDA for Eteplirsen by year end 2014. Shares of Prosnesa (RNA), another drugmaker working on a competing DMD drug, are up more than 12%... AstraZeneca (AZN), up 6% after the Sunday Times says that Pfizer (PFE) is considering a takeover bid for the company. Pfizer is up 1.2% following the report... Newmont Mining (NEM), up 8% after WSJ says the company and Barrick Gold (ABX) could resume merger talks as soon as today... Cbeyond (CBEY), up 39% after agreeing to be acquired for about $323M by Birch Communications... Momenta Pharma (MNTA), up 10.5% after the Supreme Court rejected Teva's (TEVA) bid to delay generic Copaxone... Nu Skin (NUS), up 5% after saying its China division will resume corporate-hosted business meetings... Micron (MU), up 4% after price target raised at Drexel Hamilton... DOWN AFTER EARNINGS: Acacia Research (ACTG), down 6%... athenahealth (ATHN), down 5.6%.
09:00 EDTAZNAstraZeneca rises 7.1%
AstraZeneca is up 7.1%, or $4.49, to $67.98
08:04 EDTGEGE unit is agent on $66M credit facility for Gold Star Foods acquisition
Subscribe for More Information
07:47 EDTAZNPfizer unlikely to have been interested in AstraZeneca, says Bernstein
Subscribe for More Information
07:46 EDTAAPLApple to add call credit payments in China, Marbridge Daily says
Subscribe for More Information
07:06 EDTAZNPfizer bid for AstraZeneca 'looks highly probable,' says Citigroup
Citigroup believes Pfizer's (PFE) reported takeover interest in AstraZeneca (AZN) "looks highly probable." Citi thinks a deal would fit Pfizer's strategic goals for immunotherapy and autoimmune disease and would also be financially attractive. The firm expects Pfizer to "aggressively" approach AstraZeneca a second time.
06:48 EDTAAPLMicrosoft faces internal & external conflicts in three segments, DigiTimes says
Subscribe for More Information
06:47 EDTAZNAstraZeneca volatility elevated, said to have been approached by Pfizer report
AstraZeneca (AZN) implied volatility is expected is to move on Pfizer (PFE) is said to have approached to propose a $101B takeover, says the Sunday Times. Overall option implied volatility of 20 is above its 26-week average of 18 according to Track Data, suggesting large price movement.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use